Implications of the PEGASUS-TIMI 54 trial for US clinical practice

OBJECTIVES: This study aims to determine the proportion of real-world patients with myocardial infarction (MI) who would have been eligible for the PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Open Heart
Egile Nagusiak: Bradley, Steven M, Hess, Gregory P, Stewart, Patrick, Armstrong, Ehrin J, Farmer, Steven A, Wasfy, Jason H, Valle, Javier Alfonso, Sandhu, Amneet, Maddox, Thomas M
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Open Heart 2017
Gaiak:
Coronary Artery Disease
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5471865/
https://ncbi.nlm.nih.gov/pubmed/28674626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2016-000580
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak